- Company Overview for TYMPA HEALTH TECHNOLOGIES LIMITED (11029091)
- Filing history for TYMPA HEALTH TECHNOLOGIES LIMITED (11029091)
- People for TYMPA HEALTH TECHNOLOGIES LIMITED (11029091)
- Charges for TYMPA HEALTH TECHNOLOGIES LIMITED (11029091)
- More for TYMPA HEALTH TECHNOLOGIES LIMITED (11029091)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
02 Sep 2024 | TM01 | Termination of appointment of Mark Nicholas John Poole as a director on 25 July 2024 | |
25 Jun 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
08 Mar 2024 | SH01 |
Statement of capital following an allotment of shares on 12 February 2024
|
|
18 Jan 2024 | AP01 | Appointment of Mr Steve Cashman as a director on 19 December 2023 | |
17 Jan 2024 | CS01 | Confirmation statement made on 4 January 2024 with updates | |
09 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 2 November 2023
|
|
18 Oct 2023 | SH08 | Change of share class name or designation | |
13 Oct 2023 | AP01 | Appointment of Mr Matthieu Vallin as a director on 6 July 2023 | |
06 Oct 2023 | TM01 | Termination of appointment of Richard Joseph Stringer as a director on 6 October 2023 | |
29 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
08 Mar 2023 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 13 February 2023
|
|
28 Feb 2023 | SH08 | Change of share class name or designation | |
28 Feb 2023 | SH08 | Change of share class name or designation | |
24 Feb 2023 | SH01 |
Statement of capital following an allotment of shares on 13 February 2023
|
|
24 Feb 2023 | SH01 |
Statement of capital following an allotment of shares on 10 February 2023
|
|
24 Feb 2023 | MA | Memorandum and Articles of Association | |
24 Feb 2023 | RESOLUTIONS |
Resolutions
|
|
22 Feb 2023 | PSC08 | Notification of a person with significant control statement | |
22 Feb 2023 | PSC07 | Cessation of Mark Nicholas John Poole as a person with significant control on 16 February 2023 | |
22 Feb 2023 | AP01 | Appointment of Mr Richard Joseph Stringer as a director on 10 February 2023 | |
17 Jan 2023 | CS01 | Confirmation statement made on 4 January 2023 with updates | |
11 Jan 2023 | PSC07 | Cessation of Savram Krishan Ramdoo as a person with significant control on 21 May 2018 | |
11 Jan 2023 | PSC01 | Notification of Mark Nicholas John Poole as a person with significant control on 4 March 2019 | |
09 Nov 2022 | AD01 | Registered office address changed from Office 402 - Spaces, 4th Floor Jubilee House 213 Oxford Street London W1D 2LF England to Landmark 33 Cavendish Square London W1G 0PW on 9 November 2022 | |
28 Oct 2022 | SH01 |
Statement of capital following an allotment of shares on 27 October 2022
|